Clinical Trial Update: Individual Patient Expanded Access IND of Hope Biosciences First Blood Relative Allogeneic Adipose-derived Mesenchymal Stem Cells (HB-adMSCs) for Pancreatic Cancer

View source ↗

Summary

An individual patient expanded access IND for Hope Biosciences' HB-adMSCs (allogeneic adipose-derived mesenchymal stem cells) to treat pancreatic cancer is no l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• HB-adMSCs (autologous adipose-derived mesenchymal stem cells)

Snippet

Sponsor: Hope Biosciences LLC | Conditions: Pancreatic Cancer | Status: NO_LONGER_AVAILABLE